logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9248114 B1

PDFFull Text
Expired
Date of Patent:
Feb. 02, 2016

Filed:

Aug. 12, 2013

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

Applicant:

Action Medicines, S.l., Madrid, ES;

Inventors:

Pedro Cuevas Sanchez, Madrid, ES;

Guillermo Gimenez Gallego, Madrid, ES;

Inigo Saenz De Tejada Morgan;

Javier Angulo Frutos, Madrid, ES;

Rosa Maria Lozano Puerto, Madrid, ES;

Antonio Romero Garrido, Madrid, ES;

Serafin Valverde Lopez, Madrid, ES;

Assignee:

Action Medicines, S.L., Madrid, ES;

Attorney:

Frommer Lawrence & Haug LLP

Primary Examiner:

Bong-Sook Baek

Int. Cl.
CPC ...
A61K 31/255 (2006.01); A61K 31/185 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/10 (2006.01); A61K 31/222 (2006.01); A61K 45/06 (2006.01); A61K 31/225 (2006.01); C07C 59/68 (2006.01); C07C 309/24 (2006.01); C07C 309/42 (2006.01); C07C 309/68 (2006.01); C07C 309/75 (2006.01); A61K 31/235 (2006.01); C07C 57/44 (2006.01); C07C 65/03 (2006.01); C07C 65/19 (2006.01); C07C 69/017 (2006.01); C07C 69/84 (2006.01);
U.S. Cl.
CPC ...
A61K 31/255 (2013.01); A61K 31/10 (2013.01); A61K 31/185 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/222 (2013.01); A61K 31/225 (2013.01); A61K 31/235 (2013.01); A61K 45/06 (2013.01); C07C 57/44 (2013.01); C07C 59/68 (2013.01); C07C 65/03 (2013.01); C07C 65/19 (2013.01); C07C 69/017 (2013.01); C07C 69/84 (2013.01); C07C 309/24 (2013.01); C07C 309/42 (2013.01); C07C 309/68 (2013.01); C07C 309/75 (2013.01);
Abstract

The present invention refers to the use of a compound of Formula (I') or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of hematological dyscrasias, including myelodysplastic syndromes (MDSs) and for improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy. In addition, it relates to the use of a compound of formula (I″) for the treatment and/or prophylaxis of cancer of an organ.

Find Patent Forward Citations

Sanchez, Pedro. (2016). Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ (U.S. Patent No. 9248114). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9248114

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…